Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2014 - 2026)
Biomarin Pharmaceutical (BMRN) posted Exchange Rate Effect of $1.4 million for Q1 2026, up 15.67% on a QoQ basis from $1.2 million in Q4 2025, and up 199.58% year-over-year from $470664.8 in Q1 2025.
Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Exchange Rate Effect history runs 13 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Exchange Rate Effect rose 199.58% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $305000.0 (down 79.49% YoY) and the FY2025 annual result came in at -$2.5 million, down 152.19% from the prior year.
- Exchange Rate Effect was $1.4 million for Q1 2026 at Biomarin Pharmaceutical, up from $1.2 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.3 million in Q2 2024 and bottomed at -$3.6 million in Q4 2023.
- A 5-year average of $297588.2 and a median of $739000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 814.81% in 2023, while the deepest fall reached 5236.62% in 2023.
- Biomarin Pharmaceutical's Exchange Rate Effect stood at $71000.0 in 2022, then plunged by 5236.62% to -$3.6 million in 2023, then surged by 168.66% to $2.5 million in 2024, then plunged by 51.32% to $1.2 million in 2025, then grew by 15.67% to $1.4 million in 2026.
- Business Quant data shows BMRN's Exchange Rate Effect at $1.4 million in Q1 2026, $1.2 million in Q4 2025, and $739000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 739,000.00 |
| Sep 30, 2025 | 739,000.00 |
| Jun 30, 2025 | -3.06 Mn |
| Jun 30, 2025 | -3.06 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | -2.90 Mn |
| Sep 30, 2024 | -2.90 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Dec 31, 2023 | -3.65 Mn |